Aaron Kantoff ^Investor

Experienced venture partner with a strong track record in the biotech industry. Co-founder and managing partner at Scion Life Sciences, with a focus on developing transformative medicines for immune and inflammatory diseases. Board member at Tourmaline Bio, RayzeBio, and Centessa Pharmaceuticals. Successfully led companies like Syntimmune and Corvidia Therapeutics to lucrative acquisitions. Holds a B.S. in Finance and International Business from NYU. Passionate about investing in innovative biotech companies and driving impactful change in the healthcare sector. Active member of Life Science Venture Capital and Professionals in the Pharmaceutical and Biotech Industry groups on LinkedIn.